4-aminoquinoline has been researched along with Alzheimer Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartolić, M; Bosak, A; Kovarik, Z; Maraković, N; Matošević, A; Opsenica, DM; Spasić, M; Zandona, A; Žunec, S | 1 |
1 other study(ies) available for 4-aminoquinoline and Alzheimer Disease
| Article | Year |
|---|---|
Evaluation of 4-aminoquinoline derivatives with an n-octylamino spacer as potential multi-targeting ligands for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Aminoquinolines; Amyloid Precursor Protein Secretases; Aspartic Acid Endopeptidases; Butyrylcholinesterase; Cholinesterase Inhibitors; HEK293 Cells; Humans; Ligands; Molecular Docking Simulation; Neuroblastoma; Structure-Activity Relationship; Trace Elements | 2023 |